272 related articles for article (PubMed ID: 27412635)
21. A miR-135b-TAZ positive feedback loop promotes epithelial-mesenchymal transition (EMT) and tumorigenesis in osteosarcoma.
Shen S; Huang K; Wu Y; Ma Y; Wang J; Qin F; Ma J
Cancer Lett; 2017 Oct; 407():32-44. PubMed ID: 28823959
[TBL] [Abstract][Full Text] [Related]
22. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL
J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer.
Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
Eur J Cancer; 2013 Jul; 49(11):2608-18. PubMed ID: 23566416
[TBL] [Abstract][Full Text] [Related]
24. TAZ
Yao CB; Zhang M; Zhou X; Lei QY; Yin M
Biochem Biophys Res Commun; 2018 Sep; 503(4):2240-2247. PubMed ID: 29953851
[TBL] [Abstract][Full Text] [Related]
25. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
[TBL] [Abstract][Full Text] [Related]
26. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
Noguchi S; Saito A; Nagase T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
[TBL] [Abstract][Full Text] [Related]
27. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
28. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
Cao X; Zhao B
Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
[TBL] [Abstract][Full Text] [Related]
29. YAP and TAZ Take Center Stage in Cancer.
Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W
Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056
[TBL] [Abstract][Full Text] [Related]
30. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
Shreberk-Shaked M; Oren M
Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214
[TBL] [Abstract][Full Text] [Related]
31. CDK1 phosphorylation of TAZ in mitosis inhibits its oncogenic activity.
Zhang L; Chen X; Stauffer S; Yang S; Chen Y; Dong J
Oncotarget; 2015 Oct; 6(31):31399-412. PubMed ID: 26375055
[TBL] [Abstract][Full Text] [Related]
32. Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer.
Lee WY; Kuo CC; Lin BX; Cheng CH; Chen KC; Lin CW
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946619
[TBL] [Abstract][Full Text] [Related]
33. Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.
Zhao Y; Yang X
Oncotarget; 2015 Sep; 6(26):21906-17. PubMed ID: 26183396
[TBL] [Abstract][Full Text] [Related]
34. WWTR1 (WW domain containing transcription regulator 1).
Zhao Y; Yang X
Atlas Genet Cytogenet Oncol Haematol; 2014 Nov; 18(11):849-852. PubMed ID: 26366208
[TBL] [Abstract][Full Text] [Related]
35. The Hippo Signaling Pathway in Pancreatic Cancer.
Ansari D; Ohlsson H; Althini C; Bauden M; Zhou Q; Hu D; Andersson R
Anticancer Res; 2019 Jul; 39(7):3317-3321. PubMed ID: 31262852
[TBL] [Abstract][Full Text] [Related]
36. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
37. WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth.
Gargini R; Escoll M; García E; García-Escudero R; Wandosell F; Antón IM
Cell Rep; 2016 Nov; 17(8):1962-1977. PubMed ID: 27851961
[TBL] [Abstract][Full Text] [Related]
38. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.
Li YW; Shen H; Frangou C; Yang N; Guo J; Xu B; Bshara W; Shepherd L; Zhu Q; Wang J; Hu Q; Liu S; Morrison CD; Sun P; Zhang J
Cell Cycle; 2015; 14(1):146-56. PubMed ID: 25602524
[TBL] [Abstract][Full Text] [Related]
39. The TAZ-miR-224-SMAD4 axis promotes tumorigenesis in osteosarcoma.
Ma J; Huang K; Ma Y; Zhou M; Fan S
Cell Death Dis; 2017 Jan; 8(1):e2539. PubMed ID: 28055015
[TBL] [Abstract][Full Text] [Related]
40. The biology of YAP/TAZ: hippo signaling and beyond.
Piccolo S; Dupont S; Cordenonsi M
Physiol Rev; 2014 Oct; 94(4):1287-312. PubMed ID: 25287865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
